Circadian variation of mineral and bone parameters in end-stage renal disease

被引:26
作者
Trivedi, Hariprasad [1 ]
Szabo, Aniko [2 ]
Zhao, Shi [2 ]
Cantor, Tom [3 ]
Raff, Hershel [4 ,5 ]
机构
[1] Med Coll Wisconsin, Dept Med, Div Nephrol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA
[3] Scantibodies Lab Inc, Santee, CA USA
[4] Med Coll Wisconsin, Dept Med, Div Endocrinol Metab & Clin Nutr, Milwaukee, WI 53226 USA
[5] Aurora St Lukes Med Ctr, Aurora Res Inst, Endocrine Res Lab, Milwaukee, WI USA
基金
美国国家卫生研究院;
关键词
Phosphate; Calcium; Parathyroid hormone; Circadian variation; End stage renal disease; VITAMIN-D DEFICIENCY; PLASMA PHOSPHATE; HEMODIALYSIS-PATIENTS; MORTALITY; RHYTHM; SUPPLEMENTATION; ERGOCALCIFEROL; PHOSPHORUS; METABOLISM; EXCRETION;
D O I
10.1007/s40620-014-0124-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Mineral and bone parameters are actively managed in end-stage renal disease (ESRD). However, whether these undergo circadian variation is not known. We investigated the circadian variation of mineral and bone parameters in patients on long-term hemodialysis. Methods Seventeen ESRD patients on long-term hemodialysis and eight volunteers without kidney disease were enrolled. Subjects had all medications that affect calcium-phosphate-parathyroid hormone balance (phosphate binders, vitamin D analogues, and calcimimetics) discontinued. Thereafter, for a period of 5 days, subjects consumed a diet controlled in calcium (1,200 mg per day) and phosphorus (1,000 mg per day) content. On the sixth day (a non-dialysis day for the ESRD patients), enrollees underwent twelve 2-h blood draws for phosphate, ionized calcium, parathyroid hormone (PTH), total 25-hydroxy vitamin D (25OHD), and fibroblast growth factor-23 (FGF-23). Results In the ESRD patients plasma phosphate demonstrated significant circadian variation (P < 0.00001). The peak occurred around 3: 30 am and nadir occurred around 11:00 am. Ionized calcium (P = 0.0036), PTH (P = 0.0004) and 25OHD (P = 0.009) also varied significantly during the circadian period; for ionized calcium peak and nadir occurred around 12:15 pm and 8:00 pm, parathyroid hormone 5:45 pm and 10:15 am, and 25OHD 9:45 am and 4:00 pm respectively. FGF-23 did not show a significant circadian variation. Only phosphate (P < 0.0001) and PTH (P = 0.00008) demonstrated circadian variation in the control group. Conclusions Blood concentrations of phosphate, calcium, PTH and 25-hydroxy vitamin D, exhibit a circadian variation in patients with ESRD. Knowledge of these phenomena is pertinent for the interpretation of clinical testing.
引用
收藏
页码:351 / 359
页数:9
相关论文
共 21 条
  • [1] Agrawal R, 2000, KIDNEY, P1071
  • [2] Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
    Block, GA
    Klassen, PS
    Lazarus, JM
    Ofsthun, N
    Lowrie, EG
    Chertow, GM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08): : 2208 - 2218
  • [3] CARRUTHERS BM, 1964, J LAB CLIN MED, V63, P959
  • [4] On the evolving nature of understanding dialysis-related disorders
    Eknoyan, G
    Lindberg, JS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : S1 - S3
  • [5] Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
    Floege, Juergen
    Kim, Joseph
    Ireland, Elizabeth
    Chazot, Charles
    Drueke, Tilman
    de Francisco, Angel
    Kronenberg, Florian
    Marcelli, Daniele
    Passlick-Deetjen, Jutta
    Schernthaner, Guntram
    Fouqueray, Bruno
    Wheeler, David C.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (06) : 1948 - 1955
  • [6] ALTERATION OF THE CIRCADIAN-RHYTHM OF INTACT PARATHYROID-HORMONE FOLLOWING A 96-HOUR FAST
    FRASER, WD
    LOGUE, FC
    CHRISTIE, JP
    CAMERON, DA
    OREILLY, DS
    BEASTALL, GH
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 40 (04) : 523 - 528
  • [7] Fuleihan GE-H, 1997, J CLIN ENDOCR METAB, V82, P281, DOI [DOI 10.1210/JC.82.1.281, DOI 10.1210/JC.82.1.281)]
  • [8] Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
    Gutierrez, Orlando M.
    Mannstadt, Michael
    Isakova, Tamara
    Rauh-Hain, Jose Alejandro
    Tamez, Hector
    Shah, Anand
    Smith, Kelsey
    Lee, Hang
    Thadhani, Ravi
    Juppner, Harald
    Wolf, Myles
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06) : 584 - 592
  • [9] Phosphorus Binders and Survival on Hemodialysis
    Isakova, Tamara
    Gutierrez, Orlando M.
    Chang, Yuchiao
    Shah, Anand
    Tamez, Hector
    Smith, Kelsey
    Thadhani, Ravi
    Wolf, Myles
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (02): : 388 - 396
  • [10] Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers
    Jean, Guillaume
    Terrat, Jean-Claude
    Vanel, Thierry
    Hurot, Jean-Marc
    Lorriaux, Christie
    Mayor, Brice
    Chazot, Charles
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (11) : 3670 - 3676